Skip to content

Nanotis

Saliva-Based Digital Infection Testing Technology

  • TOP
  • CONCEPT
  • TEAM
  • NEWS
  • RECRUITING
  • CONTACT US
  • 日本語日本語
Nanotis > news > We have been selected for MedTech Innovator Asia Pacific 2024 Accelerator Cohort Program

We have been selected for MedTech Innovator Asia Pacific 2024 Accelerator Cohort Program

5/30/20249/27/2024 Lisa Sakashita

We have been selected for MedTech Innovator Asia Pacific 2024 Accelerator Cohort Program. See more

news

Post navigation

Started a collaborative research with the Influenza Virus Research Center at the National Institute of Infectious Diseases
Rised Seed2 round from Eiken chemical

Latest News

  • We will be exhibiting at the GHIT Fund R&D Forum 11/11/2024
  • Rised Seed2 round from Eiken chemical 10/31/2024
  • We have been selected for MedTech Innovator Asia Pacific 2024 Accelerator Cohort Program 5/30/2024
  • Started a collaborative research with the Influenza Virus Research Center at the National Institute of Infectious Diseases 11/15/2023
  • Raised from Niporo Corporetion 7/15/2022
  • TOP
  • CONCEPT
  • TEAM
  • NEWS
  • RECRUITING
  • CONTACT US
  • 日本語日本語

Nanotis Corporation
Established in June 2016
Tokyo, Japan

info@nanotis.net

Copyright © 2022 Nanotis Corporation